Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3841 - 3848 of 11617 results
Mintz Partner Tapped to Help Get COVID-19 Relief Fund Up and Running
April 17, 2020| News
The NLRB's Final Joint-Employer Rule Will Soon Be In Effect
April 17, 2020| Blog| Viewpoint
State Securities Regulators Renew Warnings of COVID-19 Investment Scams
April 17, 2020| Blog| Viewpoint
Supreme Court Clarifies Race Discrimination Claims Under 42 U.S.C. § 1981 Must Meet More Stringent “But-For” Causation Standard
April 17, 2020| Blog| Viewpoint
ML Strategies COVID-19 Insights Week In Review — April 17, 2020
April 17, 2020| Article| Viewpoint
TCPA Litigation Update — Circuit Split Deepens on What Constitutes an ATDS Under the TCPA
April 16, 2020| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.